Shared genetic causes of cardiac hypertrophy in children and adults

New England Journal of Medicine

Volumn 358, Issue 18, 2008, Pages 1899-1908

  Morita, Hiroyuki ^a   Rehm, Heidi L ^a   Menesses, Andres ^d   McDonough, Barbara ^a,b   Roberts, Amy E ^a,c   Kucherlapati, Raju ^a   Towbin, Jeffrey A ^d   Seidman, J G ^a   Seidman, Christine E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TROPOMYOSIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MUSCLE PROTEIN; PROTEIN; PROTEIN ACTC; PROTEIN MYBPC3; PROTEIN MYH7; PROTEIN MYL2; PROTEIN MYL3; PROTEIN PRKAG2; PROTEIN TNNI3; PROTEIN TNNT2;

ADOLESCENT; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOMYOPATHY; CHILD; CHILDHOOD; DEFIBRILLATOR; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GENE DELETION; GENE MUTATION; GENETIC CODE; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SUDDEN DEAFNESS;

EID: 42949149810     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa075463     Document Type: Article

References (38)

1. SE Lipshultz LA Sleeper JA Towbin The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 2003 1647 1655
2. AW Nugent PE Daubeney P Chondros The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 348 2003 1639 1646
3. AW Nugent PE Daubeney P Chondros Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112 2005 1332 1338
4. SD Colan SE Lipshultz AM Lowe Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115 2007 773 781
5. AT Yetman BW McCrindle Management of pediatric hypertrophic cardiomyopathy. Curr Opin Cardiol 20 2005 80 83
6. BJ Maron Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 51 2004 1305 1346
7. JG Seidman C Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 2001 557 567
8. JM Lind C Chiu C Semsarian Genetic basis of hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther 4 2006 927 934
9. A Osio L Tan SN Chen Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res 100 2007 766 768
10. BJ Maron WJ McKenna GK Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 2003 1687 1713
11. M Arad DW Benson AR Perez-Atayde Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 109 2002 357 362
12. B Burwinkel JW Scott C Buhrer Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet 76 2005 1034 1049
13. M Arad BJ Maron JM Gorham Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 352 2005 362 372
14. AE Roberts B Hult HL Rehm The PTPN11 gene is not implicated in nonsyndromic hypertrophic cardiomyopathy. Am J Med Genet A 132 2005 333 334
15. CardioGenomics Project Web site. The program in genomics applications. Boston: NHLBI Program for Genomic Applications, Harvard Medical School, 2007. (Accessed April 7, 2008, at http://cardiogenomics.med.harvard.edu .)
16. SAS-STAT user's guide: release 8.1. Cary, NC: SAS Institute, 2000.
17. ST Sherry MH Ward M Kholodov dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29 2001 308 311
18. SL Van Driest MA Jaeger SR Ommen Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44 2004 602 610
19. DM Church CJ Stotler JL Rutter JR Murrell JA Trofatter AJ Buckler Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nat Genet 6 1994 98 105
20. V Probst F Kyndt F Potet Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease. J Am Coll Cardiol 41 2003 643 652
21. H Watkins D Conner L Thierfelder Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 11 1995 434 437
22. J Ingles A Doolan C Chiu J Seidman C Seidman C Semsarian Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 42 2005 e59
23. H Watkins A Rosenzweig DS Hwang Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 326 1992 1108 1114
24. L Fananapazir ND Epstein Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89 1994 22 32
25. SL Van Driest MJ Ackerman SR Ommen Prevalence and severity of “benign” mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation 106 2002 3085 3090
26. P Richard P Charron L Carrier Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 2003 2227 2232
27. EJ Gruver D Fatkin GA Dodds Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation. Am J Cardiol 83 1999 13H 18H
28. MW Consevage GC Salada BG Baylen RL Ladda PK Rogan A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet 3 1994 1025 1026
29. ND Epstein GM Cohn F Cyran L Fananapazir Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene: a 908Leu→Val mutation and a 403Arg→Gln mutation. Circulation 86 1992 345 352
30. SL Van Driest VC Vasile SR Ommen Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44 2004 1903 1910
31. H Niimura LL Bachinski S Sangwatanaroj Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 338 1998 1248 1257
32. M Alders R Jongbloed W Deelen The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur Heart J 24 2003 1848 1853
33. H Watkins WJ McKenna L Thierfelder Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 332 1995 1058 1064
34. H Morita MG Larson SC Barr Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study. Circulation 113 2006 2697 2705
35. H Morita SR DePalma M Arad Molecular epidemiology of hypertrophic cardiomyopathy. Cold Spring Harb Symp Quant Biol 67 2002 383 388
36. R Anan H Niimura T Takenaka S Hamasaki C Tei Mutations in the genes for sarcomeric proteins in Japanese patients with onset sporadic hypertrophic cardiomyopathy after age 40 years. Am J Cardiol 99 2007 1750 1754
37. H Niimura KK Patton WJ McKenna Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105 2002 446 451
38. J Flavigny M Souchet P Sebillon COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. J Mol Biol 294 1999 443 456